{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:05:47Z","timestamp":1791187547854,"version":"4.1.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.parkreldis.2007.11.008","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T11:59:41Z","timestamp":1205409581000},"page":"448-449","source":"Crossref","is-referenced-by-count":36,"title":["Topiramate in managing impulse control disorders in Parkinson's disease"],"prefix":"10.1016","volume":"14","author":[{"given":"Pedro Emilio","family":"Bermejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2007.11.008_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02938408","article-title":"Management of impulse control disorders in Parkinson's disease","volume":"9","author":"Galpern","year":"2007","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.parkreldis.2007.11.008_bib2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.biopsych.2006.08.008","article-title":"Topiramate for the treatment of binge eating disorder associated with obesity:\u00a0a placebo-controlled study","volume":"61","author":"McElroy","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.parkreldis.2007.11.008_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.wnf.0000152623.46474.07","article-title":"Topiramate versus fluvoxamine in the treatment of pathological gambling:\u00a0a randomized, blind-rater comparison study","volume":"28","author":"Dannon","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.parkreldis.2007.11.008_bib4","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/01.wnl.0000243252.71365.81","article-title":"Repetitive and impulsive behaviors in treated Parkinson disease","volume":"67","author":"Black","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2007.11.008_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/mds.20345","article-title":"Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease","volume":"20","author":"Silverdale","year":"2005","journal-title":"Mov Disord"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802007002453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802007002453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T02:55:29Z","timestamp":1546224929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802007002453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1353802007002453"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2007.11.008","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}